Roche Diagnostics
Search Contact Legal Statement
Index Sitemap link to Roche

Virology
HPV & CT/NG
Microbiology
Genomics & Oncology
 


The Roche Molecular Diagnostics' virology product portfolio is based on the company's Nobel Prize-winning real-time PCR technology. The company's quantitative tests for HIV-1, hepatitis B * & C, and cytomegalovirus * provide actionable health information that can be used to help physicians determine viral load and monitor their patients' disease progression and response to therapy.

The COBAS® AmpliPrep/COBAS® TaqMan® System is the first fully automated real-time, continuous load IVD platform, featuring sample-in, result-out capability. It is designed for those who want to increase laboratory efficiency and productivity with automated sample preparation, amplification and quantitation of RNA or DNA *. For higher throughput labs, the system is available in a fully docked configuration. The HIV-1, HCV, and HBV tests on this platform have been available in Europe since 2005. The HIV-1 test was approved for use in the U.S. in May of 2007.

The full menu of tests utilizing real-time PCR technology provides excellent sensitivity, specificity and broad linear range, minimizing the need for repeated testing or dilutions.

Please note: Not all products are available in all countries.

Viral Assays

* Not available in the United States
** Not available in the United States or the EU
*** This product is for Research Use Only and is not available in all markets
**** Available as an IVD in the EU and for Research Use Only in the United States
***** This product is available only in the U.S.
1 Two different specimen preparations, UltraSensitive and Standard

Instruments

Commitment and Care across the Globe
(PDF Document, 770 KB) 2002

If you would like more information, please Contact Us

ROCHE, COBAS, AMPLILINK, AMPLIPREP, AMPERASE, AMPLICOR, LIGHTCYCLER and TAQMAN are trademarks of Roche.

 
© 2009, Roche Diagnostics See our Legal Statement - Privacy Policy
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.
 
Visitor Insights Survey
Welcome to Roche Molecular Diagnostics

Whether you are a first-time visitor or a frequent visitor, we would appreciate your opinion to help improve our Web site.

Would you be willing to answer a brief questionnaire? It will take less than 5 minutes.

YesNo, thanks

This questionnaire is voluntary and your use of this Web site is not conditional upon your participation.

The questionnaire does not include any health-related questions, it strictly focuses on Web-related topics. In accordance to Roche's privacy policy, your responses will be treated with the strictest of confidence and not passed on to any third parties for their marketing purposes.